Register
Medicines reference
Product

Enterogermina

· Sanofi / Opella, Opella Healthcare

3 forms: capsule, powder, suspension. In force in Georgia: 3 of 3 (human register).

Forms and doses3 of 3 in force in Georgia

Form Dose Frequency Georgia
2 billion, Capsule No label dose in the reference yet - Georgia Yes, human
In force until 08 Apr 2027
Human (Ministry of Health, RAMA)
In the register: ენტეროგერმინა 2 მილიარდი, კაფსულა
№ რ-041198
Verified on: 16 Oct 2026
Details: pack, label wording, sources, registration

Enterogermina 2 billion, Capsule

hard capsule, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Off-label in dogs: human Bacillus clausii spore probiotic (2 billion spores per capsule), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea
Not rateable
No numerical score assigned
vetman assessment

Enterogermina

2 billion, hard capsule, human medicine
Assessed clinical scopeDog · Off-label in dogs: human Bacillus clausii spore probiotic (2 billion spores per capsule), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea · By mouth
Care settingVeterinary-directed adjunct under the cascade, alongside standard supportive care of diarrhoea
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, human · № რ-041198 · Verified on 16 Oct 2026 Off-label use
Not rateable

Not rateable for dogs or cats: these are human Bacillus clausii presentations with no authoritative veterinary dose, no target-animal safety study and no controlled clinical outcome study for the assessed diarrhoea role.

Human product identity is documented, but the veterinary evidence needed for a numerical benefit-risk score is absent.

Important safety and use flags

  • Bloody diarrhoea, repeated vomiting, lethargy, fever or dehydration need veterinary assessment and supportive care; a probiotic does not treat them.
  • Oral use only; do not use with hypersensitivity to the spores or excipients.
  • Veterinary safety is not established; avoid use in immunosuppressed or critically ill animals and in patients with central venous catheters.
  • No veterinary interaction study establishes timing with antibiotics; do not infer a dog or cat regimen from human instructions.
  • Human medicine with no veterinary dose; record the off-label use and the amount given.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Cat Off-label in cats: human Bacillus clausii spore probiotic (2 billion spores per capsule), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea
Not rateable
No numerical score assigned
vetman assessment

Enterogermina

2 billion, hard capsule, human medicine
Assessed clinical scopeCat · Off-label in cats: human Bacillus clausii spore probiotic (2 billion spores per capsule), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea · By mouth
Care settingVeterinary-directed adjunct under the cascade, alongside standard supportive care of diarrhoea
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, human · № რ-041198 · Verified on 16 Oct 2026 Off-label use
Not rateable

Not rateable for dogs or cats: these are human Bacillus clausii presentations with no authoritative veterinary dose, no target-animal safety study and no controlled clinical outcome study for the assessed diarrhoea role.

Human product identity is documented, but the veterinary evidence needed for a numerical benefit-risk score is absent.

Important safety and use flags

  • Bloody diarrhoea, repeated vomiting, anorexia, lethargy or dehydration need veterinary assessment and supportive care; a probiotic does not treat them.
  • Oral use only; do not use with hypersensitivity to the spores or excipients.
  • Veterinary safety is not established; avoid use in immunosuppressed or critically ill animals and in patients with central venous catheters.
  • No veterinary interaction study establishes timing with antibiotics; do not infer a dog or cat regimen from human instructions.
  • Human medicine with no veterinary dose; record the off-label use and the amount given.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Composition / strength
Formulation Type
Capsule
Administration route
By mouth
Manufacturer
Sanofi / Opella · France
Registration
Georgia Yes, human
In force until 08 Apr 2027
Human (Ministry of Health, RAMA)
In the register: ენტეროგერმინა 2 მილიარდი, კაფსულა
№ რ-041198
Verified on: 16 Oct 2026
EU Yes, human
UK No
Verified on: 16 Oct 2026
US No
Verified on: 16 Oct 2026
Controlled in Georgia
Unknown
2 billion/5 ml, Suspension No label dose in the reference yet - Georgia Yes, human
Details: pack, label wording, sources, registration

Enterogermina 2 billion/5 ml, Suspension

oral suspension, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Off-label in dogs: human Bacillus clausii spore probiotic (2 billion spores per 5 ml vial), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea
Not rateable
No numerical score assigned
vetman assessment

Enterogermina

2 billion/5 ml, oral suspension, human medicine
Assessed clinical scopeDog · Off-label in dogs: human Bacillus clausii spore probiotic (2 billion spores per 5 ml vial), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea · By mouth
Care settingVeterinary-directed adjunct under the cascade, alongside standard supportive care of diarrhoea
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, human · № რ-040741 · Verified on 15 Oct 2026 Off-label use
Not rateable

Not rateable for dogs or cats: these are human Bacillus clausii presentations with no authoritative veterinary dose, no target-animal safety study and no controlled clinical outcome study for the assessed diarrhoea role.

Human product identity is documented, but the veterinary evidence needed for a numerical benefit-risk score is absent.

Important safety and use flags

  • Oral presentation only: never inject the contents. Do not use with hypersensitivity to the spores or excipients.
  • Bloody diarrhoea, repeated vomiting, lethargy, fever or dehydration need veterinary assessment and supportive care; a probiotic does not treat them.
  • Veterinary safety is not established; avoid use in immunosuppressed or critically ill animals and in patients with central venous catheters.
  • No veterinary interaction study establishes timing with antibiotics; do not infer a dog or cat regimen from human instructions.
  • Human medicine with no veterinary dose; record the off-label use and the amount given.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Cat Off-label in cats: human Bacillus clausii spore probiotic (2 billion spores per 5 ml vial), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea
Not rateable
No numerical score assigned
vetman assessment

Enterogermina

2 billion/5 ml, oral suspension, human medicine
Assessed clinical scopeCat · Off-label in cats: human Bacillus clausii spore probiotic (2 billion spores per 5 ml vial), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea · By mouth
Care settingVeterinary-directed adjunct under the cascade, alongside standard supportive care of diarrhoea
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, human · № რ-040741 · Verified on 15 Oct 2026 Off-label use
Not rateable

Not rateable for dogs or cats: these are human Bacillus clausii presentations with no authoritative veterinary dose, no target-animal safety study and no controlled clinical outcome study for the assessed diarrhoea role.

Human product identity is documented, but the veterinary evidence needed for a numerical benefit-risk score is absent.

Important safety and use flags

  • Oral use only: never inject the vial contents; injection has caused severe anaphylactic reactions. Do not use with hypersensitivity to the spores or excipients.
  • Bloody diarrhoea, repeated vomiting, anorexia, lethargy or dehydration need veterinary assessment and supportive care; a probiotic does not treat them.
  • Avoid in immunosuppressed or critically ill cats and in cats with central venous catheters, because Bacillus clausii bloodstream infections are reported in such people.
  • If given during antibiotic treatment, give it between antibiotic doses, as the human label advises.
  • Human medicine with no veterinary dose; record the off-label use and the amount given.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Composition / strength
Formulation Type
Suspension
Administration route
By mouth
Manufacturer
Sanofi / Opella · France
Registration
Georgia Yes, human
EU Yes, human
UK No
Verified on: 16 Oct 2026
US No
Verified on: 16 Oct 2026
Controlled in Georgia
Unknown
6 billion, Powder No label dose in the reference yet - Georgia Yes, human
In force until 25 Mar 2030
Human (Ministry of Health, RAMA)
In the register: ენტეროგერმინა 6 მილიარდი, ფხვნილი პაკეტში
№ რ-043016
Verified on: 16 Oct 2026
Details: pack, label wording, sources, registration

Enterogermina 6 billion, Powder

powder for oral suspension, sachet, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Off-label in dogs: human Bacillus clausii spore probiotic (6 billion spores per sachet), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea
Not rateable
No numerical score assigned
vetman assessment

Enterogermina

6 billion, powder for oral suspension, sachet, human medicine
Assessed clinical scopeDog · Off-label in dogs: human Bacillus clausii spore probiotic (6 billion spores per sachet), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea · By mouth
Care settingVeterinary-directed adjunct under the cascade, alongside standard supportive care of diarrhoea
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, human · № რ-043016 · Verified on 16 Oct 2026 Off-label use
Not rateable

Not rateable for dogs or cats: these are human Bacillus clausii presentations with no authoritative veterinary dose, no target-animal safety study and no controlled clinical outcome study for the assessed diarrhoea role.

Human product identity is documented, but the veterinary evidence needed for a numerical benefit-risk score is absent.

Important safety and use flags

  • Bloody diarrhoea, repeated vomiting, lethargy, fever or dehydration need veterinary assessment and supportive care; a probiotic does not treat them.
  • Oral use only; do not use with hypersensitivity to the spores or excipients.
  • Veterinary safety is not established; avoid use in immunosuppressed or critically ill animals and in patients with central venous catheters.
  • No veterinary interaction study establishes timing with antibiotics; do not infer a dog or cat regimen from human instructions.
  • Human medicine with no veterinary dose; record the off-label use and the amount given.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Cat Off-label in cats: human Bacillus clausii spore probiotic (6 billion spores per sachet), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea
Not rateable
No numerical score assigned
vetman assessment

Enterogermina

6 billion, powder for oral suspension, sachet, human medicine
Assessed clinical scopeCat · Off-label in cats: human Bacillus clausii spore probiotic (6 billion spores per sachet), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea · By mouth
Care settingVeterinary-directed adjunct under the cascade, alongside standard supportive care of diarrhoea
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, human · № რ-043016 · Verified on 16 Oct 2026 Off-label use
Not rateable

Not rateable for dogs or cats: these are human Bacillus clausii presentations with no authoritative veterinary dose, no target-animal safety study and no controlled clinical outcome study for the assessed diarrhoea role.

Human product identity is documented, but the veterinary evidence needed for a numerical benefit-risk score is absent.

Important safety and use flags

  • Bloody diarrhoea, repeated vomiting, anorexia, lethargy or dehydration need veterinary assessment and supportive care; a probiotic does not treat them.
  • Oral use only; do not use with hypersensitivity to the spores or excipients.
  • Veterinary safety is not established; avoid use in immunosuppressed or critically ill animals and in patients with central venous catheters.
  • No veterinary interaction study establishes timing with antibiotics; do not infer a dog or cat regimen from human instructions.
  • Human medicine with no veterinary dose; record the off-label use and the amount given.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Composition / strength
Formulation Type
Powder
Administration route
By mouth
Manufacturer
Registration
Georgia Yes, human
In force until 25 Mar 2030
Human (Ministry of Health, RAMA)
In the register: ენტეროგერმინა 6 მილიარდი, ფხვნილი პაკეტში
№ რ-043016
Verified on: 16 Oct 2026
EU Yes, human
UK No
Verified on: 16 Oct 2026
US No
Verified on: 16 Oct 2026
Controlled in Georgia
Unknown

No dose supported by a publicly verifiable source yet

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.